Singapore, Sept. 15 -- SHIRE ACQUISITIONS INVESTMENTS IRELAND DESIGNATED ACTIVITY COMPANY made the following announcement:
Security Name: NA
General Announcement::U.S. FDA Accepts New Drug Application Under Priority Review for Takeda Zasocitinib (https://links.sgx.com/1.0.0/corporate-announcements/4184TJJOP54KSZB1/87d9be4083c91efaca45fe05d471a59b4a835b3b68b90f45a31aedd98c3c7285)
Published by HT Digital Content Services with permission from South East Asian News....